跳至主要内容
临床试验/NCT02918305
NCT02918305已完成3 期

A Clinical Study of the Ultrasound Renal Denervation System in Patients With Resistant Hypertension

JIMRO Co., Ltd.53 个研究点 分布在 2 个国家目标入组 140 人开始时间: 2017年1月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
140
试验地点
53
主要终点
a decrease of average 24-hr ambulatory systolic BP from the baseline

研究概览

简要总结

The REQUIRE STUDY is a multi-center, randomized, double-blind, sham-controlled study, which aims to confirm the efficacy and safety of PRDS-001 (ReCor Medical Inc. Paradise in Europe) for renal denervation therapy in patients with treatment resistance hypertension, in comparison with the sham procedure.

详细描述

Patients with treatment resistance hypertension is defined patients being treated on 3 or more different classes of antihypertensive medications including diuretics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • average office systolic BP of 150 mmHg or greater or office diastolic BP of 90 mmHg or greater (both in the sitting position)
  • 24-hr ambulatory BP 140 mmHg or greater.

排除标准

  • Secondary hypertension (sleep apnoea can be included.)
  • Type I diabetes or uncontrolled Type II diabetes with HbA1c 8.4% or greater
  • Known or concurrent chronic active inflammatory bowel diseases (e.g. Crohn's disease, ulcerative colitis etc.)
  • eGFR<40 mL/min/1.73m2 (per predictive equation Japanese Society of Nephrology)
  • Known severe cardiovascular events within 3 months or severe cerebrovascular events
  • Patients those who are planned to receive PCI or other operation for iscaemic cardiovascular disease within 8 months
  • Concurrent persistent atrial fibrillation
  • Patients those who are on active implantable medical devices
  • Primary pulmonary hypertension
  • Patients those who are contraindicated to, or confirmed to have intolerable anaphylactic reaction or uncontrollable allergy to contrast media

结局指标

主要结局

a decrease of average 24-hr ambulatory systolic BP from the baseline

时间窗: 3 month follow-up visit

次要结局

  • a decrease of the average office BP (both systolic and diastolic) in the sitting position from the baseline(3 month follow-up visit)
  • a decrease of the average ambulatory systolic BP during the daytime and that during the nighttime, from the baseline, respectively(3 month follow-up visit)
  • a decrease of the average ambulatory diastolic BP during the daytime, and that during the nighttime, from the baseline, respectively(3 month follow-up visit)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (53)

Loading locations...

相似试验